TCL Archive Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS. February 15, 2002
TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013